Symptomatic and asymptomatic Coxiella burnetii infection during pregnancy have been associated with obstetric complications. We described placental histopathology and clinical outcome of five cases with asymptomatic C. burnetii infection during pregnancy and compared these cases with four symptomatic cases from the literature. In contrast with the symptomatic cases, we did not observe necrosis or active inflammation in the placentas of the asymptomatic women. Obstetrical outcome was more favourable in the asymptomatic cases than in the symptomatic cases. Asymptomatic and symptomatic C. burnetii infection during pregnancy are different entities with respect to placental histopathology and the risk of obstetric complications.
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Introduction
Several European countries notified increasing numbers of human Q fever since 2007 [1, 2] . Q fever is a zoonosis caused by the intracellular bacterium Coxiella burnetii. It primarily infects ruminants and rodents, in which the infection is mainly associated with miscarriage and stillbirth [3] . Humans are predominantly infected by inhalation of contaminated aerosols [4] .
Up to 90% of pregnant women with antibodies suggesting recent infection with C. burnetii remain asymptomatic [5] . However, symptomatic and asymptomatic C. burnetii infection during pregnancy have been associated with obstetric complications, including miscarriage, preterm delivery and fetal death [6, 7] . Placental infection assessed by polymerase chain reaction (PCR) or culture has been strongly related to these complications [6] . However, information about placental histopathology, in particular in asymptomatic cases, is lacking. Therefore, we described placental histopathology from women with asymptomatic C. burnetii infection during pregnancy. Subsequently, we compared our results with symptomatic cases described in the literature.
Patients and methods

Setting and participants
This study was embedded in a clustered randomised controlled trial about the effectiveness of a screening program for C. burnetii infection during pregnancy. In that study pregnant women living in Q fever high-risk areas in The Netherlands were serologically screened for C. burnetii infection. Details about the screening study are described elsewhere [8] . The study protocol was approved by the Medical Ethical Review Board of the University Medical Centre Groningen (UMCG). All participants included in this study gave written informed consent to collect and analyse placental tissue and clinical outcome data.
Design
From women who participated in the intervention group of the screening trial and who had serological evidence for an acute infection, placentas were collected. An acute infection was defined as the presence (cut-off titre ! 1:32) of immunoglobulin (Ig)M accompanied with (rising) IgG during follow-up. Serology was performed with indirect immunofluorescence assay (IFA, Focus Diagnostics, Cypress, CA, USA). Placentas were histopathologically analysed by one pathologist (AT) from the UMCG. Furthermore, C. burnetii specific real-time PCR was performed. Primers and probes used have been described earlier [9] , other technical details are available on request.
Systematic review
A systematic review of the literature was done by searching PubMed and the references of the included papers following the PRISMA-guidelines. Our search was limited to human studies in English or Dutch. The search strategy was: ''Q fever OR Abbreviations: g, grams; IFA, indirect immunofluorescence assay; Ig, immunoglobulin; NA, not applicable; PCR, polymerase chain reaction; PPROM, preterm premature rupture of membranes; UMCG, University Medical Centre Groningen; wks, weeks; y, years.
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Results
Seven of the 536 women in the intervention group of the screening trial had serological profiles suggesting an acute C. burnetii infection and were treated with antibiotics. Overall, five placentas were stored and send for re-evaluation to the UMCG, including two placentas from women with follow-up serology suggesting a previous infection. All cases were asymptomatic at the moment of screening. Clinical outcome and placental histopathology are summarised in the first part of Table 1 .
The PubMed search resulted in 30 hits. Only 2 papers included data on human placental histopathology and were included. Two other reports were included based on the references. All included papers concerned case-reports of symptomatic acute or chronic Q fever cases [10e13] . Clinical outcome and placental histopathology of these cases are summarised in the second part of Table 1 .
Discussion
We showed that asymptomatic and symptomatic C. burnetii infection during pregnancy are different entities with respect to placental pathology and the risk of obstetric complications. Placental histology in the asymptomatic cases showed, in contrast with the symptomatic cases, no foci of necrosis or active inflammation. We only observed a few scattered fibrotic villi, which could be a result of interruption of fetal blood flow or destruction of capillaries due to previous villitis [14] . The presence of low grade chronic villitis is a frequent finding in third trimester placentas and probably related to a maternal immune response directed against fetal antigens inherited from the father. Until present no microbiological pathogens have been linked to chronic villitis [15] . Whether placenta hypoplasia and pathology consistent with maternal vascular underperfusion are linked to C. burnetii infection is to our knowledge unknown.
In none of the placentas from asymptomatic cases C. burnetii could be detected with PCR. Previously this also has been shown for a larger cohort of 153 asymptomatic seropositive women [7] , suggesting that the rate of placental infection during asymptomatic C. burnetii infection is very low.
Our findings are in line with animal studies. In cows, where Q fever is usually not clinically apparent, positive PCR on bulk tank milk is only rarely associated with histopathological inflammation of placentas [16] . On the other hand, in goats and sheep, in which C. burnetii infection is often associated with miscarriage and stillbirth, necrotising inflammation of placental tissue is a common finding [17, 18] .
Various factors, including host immune response, cytokines and different strains of C. burnetii, have been suggested to play a role in the clinical manifestation and outcome of C. burnetii infection in both animals and humans, but further research is needed to find target points for prevention and treatment [18e20].
In conclusion, after asymptomatic C. burnetii infection during pregnancy placental examination reveals no major pathology related to previous villitis, which is associated with a favourable clinical outcome. Symptomatic infection is a different entity. Obstetric complications in these cases can very well be explained by colonisation with C. burnetii and massive necrosis of the placenta.
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